Philip Storey

1.8k total citations
59 papers, 1.1k citations indexed

About

Philip Storey is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Philip Storey has authored 59 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Ophthalmology, 14 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Molecular Biology. Recurrent topics in Philip Storey's work include Retinal Diseases and Treatments (31 papers), Ocular Diseases and Behçet’s Syndrome (22 papers) and Ocular Infections and Treatments (20 papers). Philip Storey is often cited by papers focused on Retinal Diseases and Treatments (31 papers), Ocular Diseases and Behçet’s Syndrome (22 papers) and Ocular Infections and Treatments (20 papers). Philip Storey collaborates with scholars based in United States, Australia and United Kingdom. Philip Storey's co-authors include Sunir J. Garg, Jason Hsu, J.F. Vander, Michael Dollin, John D. Pitcher, Nadim Rayess, Anthony Obeid, Benjamin E. Leiby, Francis Char DeCroos and Jeremy D. Wolfe and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and The Journal of Infectious Diseases.

In The Last Decade

Philip Storey

55 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip Storey United States 19 853 314 85 82 77 59 1.1k
Amit Bhardwaj India 17 105 0.1× 144 0.5× 44 0.5× 88 1.1× 154 2.0× 98 705
Sannapaneni Krishnaiah India 24 1.2k 1.4× 925 2.9× 116 1.4× 261 3.2× 630 8.2× 42 1.8k
B. Vennemann Germany 14 128 0.2× 119 0.4× 91 1.1× 46 0.6× 29 0.4× 27 475
Andréa Zin Brazil 19 221 0.3× 964 3.1× 62 0.7× 426 5.2× 351 4.6× 56 1.5k
Mitsuaki Tokumura Japan 9 89 0.1× 97 0.3× 69 0.8× 72 0.9× 208 2.7× 22 384
Mikako Inokuchi Japan 13 80 0.1× 93 0.3× 63 0.7× 261 3.2× 142 1.8× 42 591
Mary Beth Howard United States 14 146 0.2× 114 0.4× 40 0.5× 169 2.1× 263 3.4× 32 823
Maria Nordwall Sweden 14 86 0.1× 69 0.2× 43 0.5× 44 0.5× 32 0.4× 22 811
Ralph S. Riffenburgh United States 12 270 0.3× 58 0.2× 17 0.2× 83 1.0× 92 1.2× 25 469
DC Minassian Mexico 5 252 0.3× 113 0.4× 13 0.2× 29 0.4× 136 1.8× 7 576

Countries citing papers authored by Philip Storey

Since Specialization
Citations

This map shows the geographic impact of Philip Storey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Storey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Storey more than expected).

Fields of papers citing papers by Philip Storey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Storey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Storey. The network helps show where Philip Storey may publish in the future.

Co-authorship network of co-authors of Philip Storey

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Storey. A scholar is included among the top collaborators of Philip Storey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Storey. Philip Storey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Adam, Murtaza K., Eliot R. Dow, Samuel A. Minaker, et al.. (2025). Artificial Intelligence in Clinical Care: Perceptions of Retina Specialists and Patients Gathered Through a Multicenter Survey. Journal of VitreoRetinal Diseases. 10(1). 68–73.
3.
Mansour, Hana A., Hasenin Al-khersan, Edward H. Wood, et al.. (2025). The Efficacy and Safety of Intravitreal Aflibercept 8 mg in Clinical Practice. Journal of VitreoRetinal Diseases. 10(1). 20–30.
4.
Al-khersan, Hasenin, Kenneth C. Fan, Edward H. Wood, et al.. (2024). Impact of a Recall of Intravitreal Bevacizumab: a Health Analytics in Ophthalmology Registry Review. Ophthalmology Retina. 8(12). 1211–1213. 1 indexed citations
5.
Patel, Sunil, Philip Storey, Mark Barakat, et al.. (2024). Phase I DAVIO Trial: EYP-1901 Bioerodible, Sustained-Delivery Vorolanib Insert in Patients With Wet Age-Related Macular Degeneration. Ophthalmology Science. 4(5). 100527–100527. 6 indexed citations
6.
Patel, Samir, Peter H. Tang, Philip Storey, et al.. (2021). The Influence of Universal Face Mask Use on Endophthalmitis Risk after Intravitreal Anti–Vascular Endothelial Growth Factor Injections. Ophthalmology. 128(11). 1620–1626. 33 indexed citations
7.
Patel, Samir, Philip Storey, Anthony Obeid, et al.. (2019). Changes in Management Based on Vitreous Culture in Endophthalmitis After Intravitreal Anti-vascular Endothelial Growth Factor Injection. American Journal of Ophthalmology. 207. 224–231. 17 indexed citations
8.
Hsu, Jason, Anthony Obeid, Turner D. Wibbelsman, et al.. (2019). Short-Term Outcomes of Eyes with Neovascular Age-related Macular Degeneration (nAMD) that Switched from Aflibercept to Ranibizumab. Investigative Ophthalmology & Visual Science. 60(9). 80–80. 2 indexed citations
9.
Gao, Xinxiao, Durga S. Borkar, Philip Storey, et al.. (2018). Incidence of retinal artery occlusion following intravitreal anti-vascular endothelial growth factor injections. Investigative Ophthalmology & Visual Science. 59(9). 5457–5457. 1 indexed citations
10.
Tauqeer, Zujaja, Philip Storey, Jeremy D. Wolfe, et al.. (2018). Endophthalmitis Rates of Ranibizumab in Pre-Filled Syringes Compared to Vials. Investigative Ophthalmology & Visual Science. 59(9). 5697–5697. 1 indexed citations
11.
Storey, Philip, et al.. (2018). OCULAR HYPERTENSION AFTER INTRAVITREAL INJECTION OF 2-MG TRIAMCINOLONE. Retina. 40(1). 75–79. 17 indexed citations
12.
Rayess, Nadim, Ehsan Rahimy, Philip Storey, et al.. (2016). Postinjection Endophthalmitis Rates and Characteristics Following Intravitreal Bevacizumab, Ranibizumab, and Aflibercept. American Journal of Ophthalmology. 165. 88–93. 83 indexed citations
13.
14.
Ma, Khan, Francis Char DeCroos, Philip Storey, et al.. (2014). OUTCOMES OF ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN THE MANAGEMENT OF CHOROIDAL NEOVASCULARIZATION ASSOCIATED WITH CHOROIDAL OSTEOMA. Retina. 34(9). 1750–1756. 19 indexed citations
15.
Pitcher, John D., Khan Ma, Philip Storey, et al.. (2013). Giant Retinal Tear Detachments: Surgical Strategies and Outcomes. Investigative Ophthalmology & Visual Science. 54(15). 2864–2864. 2 indexed citations
16.
Zangalli, Camila, Ann P. Murchison, Yang Dai, et al.. (2013). Educational and Personal Reminders to Improve Follow-Up to Vision Care in Patients with Diabetes: A Prospective, Randomized Trial. Investigative Ophthalmology & Visual Science. 54(15). 215–215. 1 indexed citations
17.
Storey, Philip, Beatriz Muñoz, David S. Friedman, & Sheila K. West. (2013). Racial Differences in Lens Opacity Incidence and Progression: The Salisbury Eye Evaluation (SEE) Study. Investigative Ophthalmology & Visual Science. 54(4). 3010–3010. 32 indexed citations
18.
Freeman, Becky, Simon Chapman, & Philip Storey. (2008). Banning smoking in cars carrying children: an analytical history of a public health advocacy campaign. Australian and New Zealand Journal of Public Health. 32(1). 60–65. 48 indexed citations
19.
Large, Matthew, et al.. (2008). Major Self-mutilation in the First Episode of Psychosis. Schizophrenia Bulletin. 35(5). 1012–1021. 83 indexed citations
20.
Storey, Philip. (1983). William Slothrop: Gentleman. 0(13). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amit Bhardwaj Breakdown of academic impact, for papers by Sannapaneni Krishnaiah Breakdown of academic impact, for papers by B. Vennemann Breakdown of academic impact, for papers by Andréa Zin Breakdown of academic impact, for papers by Mitsuaki Tokumura Breakdown of academic impact, for papers by Mikako Inokuchi Breakdown of academic impact, for papers by Mary Beth Howard Breakdown of academic impact, for papers by Maria Nordwall Breakdown of academic impact, for papers by Ralph S. Riffenburgh Breakdown of academic impact, for papers by DC Minassian
Rankless by CCL
2026